Economics / Markets

Neil Woodford's top ten holdings in his Woodford Equity Income fund contain few surprises, with AstraZeneca, GlaxoSmithKline and British American Tobacco the three largest positions.

Ian McVeigh and Steve Davies, managers of the £1.1bn Jupiter UK Growth fund, have said domestic investors should be wary of a number of ‘disruptive events' which could impact share prices over the next 12 months.

The Dow Jones Industrial Average has closed above 17,000 for the first time, buoyed by investor confidence about the global economy.

Knock-out: High yield vs. investment grade

What are the biggest risks facing investors in H2?

Asian indices hit a fresh six-year high this morning after positive manufacturing data helped lift sentiment.

US authorities have hit French bank BNP Paribas with a giant $8.9bn (£5.2bn) fine for breaking trade sanctions.

The Retail Distribution Review (RDR) has resulted in a small number of gatekeepers at financial adviser firms, investment platforms, discretionary and wealth managers steering more money into fewer, bigger funds, research has suggested.

The reversal of fortunes for the IMA UK All Companies sector this year has again raised the question of whether investors' buying patterns are leaving them exposed to market corrections.

The outgoing Bank of England (BoE) deputy governor Sir Charlie Bean has said it is "reasonable" to expect interest rates to return to 5% within a decade.